Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7415 p244
26 August 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacist telephone counselling can improve patient outcomes

Telephone counselling

Telephone counselling may increase patients’ awareness of their conditions

Periodic telephone counselling by a pharmacist improves compliance and reduces mortality in patients receiving five or more drugs, a new study reveals (BMJ Online First).

The study was carried out in Hong Kong, which has a heavily subsidised health care system. For each clinic visit, patients pay an average fee of £7–£14, which includes any drug costs.

From 1,011 interviews with patients taking multiple drugs for chronic conditions, 502 non-compliant patients were identified and invited to take part in a randomised, controlled study. However, 60 of these patients defaulted at the next clinic visit. Most patients were taking drugs for cardiovascular diseases, and had an estimated annual mortality of 10 per cent.

Patients in the intervention group received a 10- to 15-minute telephone call from the pharmacist, who asked about their treatment regimens, clarified any misconceptions, explained the nature of any side effects, reminded patients of their next clinic appointment, and reinforced the importance of compliance with treatment and relevant aspects of self care such as diet, exercise, and self monitoring.

After two years, 52 per cent of the defaulters, 17 per cent of the control group, and 11 per cent of the intervention group had died. After adjusting for various factors, telephone counselling was associated with a 41 per cent reduction in the risk of death (relative risk 0.59, 95 per cent confidence interval 0.35–0.97; P=0.039). The researchers also found that the intervention group had a lower use of health care resources than did the control group.

The authors claim the telephone calls triggered discussion about the patient’s health and led to a greater awareness and a more proactive role by patients and their carers towards their conditions.

Back to Top


©The Pharmaceutical Journal